FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

Supplemental approval for a generic buprenorphine/naloxone product by Camber Pharmaceuticals, Inc. (ANDA 219850).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Pain Management

Drugs mentioned

• Buprenorphine and naloxone (BUPRENORPHINE AND NALOXONE)

Snippet

SUPPL AP for BUPRENORPHINE AND NALOXONE (BUPRENORPHINE AND NALOXONE)